- Product NDC
- 84999-030
- 11-digit product format
- 849990030
- Labeler code
- 84999
- Product ID
- 84999-030_3e49a812-789c-646c-e063-6294a90a5830
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Calcarea Fluorica,Calcarea Phosphorica,Calcarea Sulphurica,Ferrum Phosphoricum ,Kali Phosphoricum,Kali Muriaticum,Kali Sulphuricum,Magnesia Phosphorica,Natrum Muriaticum,Natrum Phosphoricum,Natrum Sulphuricum,Silicea
- Dosage form
- SPRAY
- Route
- ORAL
- Labeler
- Martin & Pleasance Pty Ltd
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2025-08-01
- Substance
- CALCIUM FLUORIDE; CALCIUM SULFATE DIHYDRATE; DIBASIC POTASSIUM PHOSPHATE; FERROUS PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM SULFATE ANHYDROUS; TRIBASIC CALCIUM PHOSPHATE
- Active strength
- 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6 [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL
- Pharmacologic classes
- Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes